Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile
Rahul Banerjee, MD, FACP

@rahulbanerjeemd

Asst Professor @UWMedicine @fredhutch. Goals: improve pt experience in myeloma #MMsm: ⬇️ dex, ⬆️ time at home, 📱-based wellness.

COI: coi.asco.org/share/VU2-FHC3…

ID: 26399236

linkhttps://www.ncbi.nlm.nih.gov/myncbi/rahul.banerjee.2/bibliography/public/ calendar_today25-03-2009 02:04:42

25,25K Tweet

9,9K Takipçi

4,4K Takip Edilen

Dr Dilip Jadhav (@sosrrt) 's Twitter Profile Photo

25 year male, adult onset nephrotic syndrome . Below are the details of his kidney biopsy report, including EM and BM aspiration and biopsy. Would like to know how you will treat this patient?Sanjeev Sethi Mayuri Trivedi Vincent Rajkumar Vijay Kher Sreejith Parameswaran Kenar Jhaveri

25 year male, adult onset nephrotic syndrome . Below are the details of his kidney biopsy report, including EM and BM aspiration and biopsy. Would like to know how you will treat this patient?<a href="/SethiRenalPath/">Sanjeev Sethi</a> <a href="/MayuriTrivedi80/">Mayuri Trivedi</a> <a href="/VincentRK/">Vincent Rajkumar</a> <a href="/VijayKher8/">Vijay Kher</a> <a href="/SreejithDr/">Sreejith Parameswaran</a> <a href="/kdjhaveri/">Kenar Jhaveri</a>
OncLive.com (@onclive) 's Twitter Profile Photo

Coombs here - had to take a break for meetings during the myeloma session (I also can’t really follow myeloma data anyway - like what actually is the SOC?!) - excited for the upcoming CLL session though! calliecoombs #SOHO24

Bilal Abid, MD, MS (@bilalabidmd) 's Twitter Profile Photo

🚨Talk of the day: “Early vs late CAR-T in Myeloma.” No consensus reached but both sides up a notch w life qoutes, sports & music references! “Just bc you can do something doesn’t mean you should do it” Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Krina Patel MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center #SOHO2024 #SOHO24

🚨Talk of the day: “Early vs late CAR-T in Myeloma.” No consensus reached but both sides up a notch w life qoutes, sports &amp; music references!  “Just bc you can do something doesn’t mean you should do it” <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a>  <a href="/DrKrinaPatel/">Krina Patel</a> <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> #SOHO2024  #SOHO24
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Dr Dilip Jadhav Sanjeev Sethi Mayuri Trivedi Vijay Kher Sreejith Parameswaran Kenar Jhaveri Adding fernando fervenza There’s no clone in the marrow or on paraprotein studies. If there was I would have suggested a short course of Dara. But Dr. Fervenza is the expert and he may be able to comment if you should try dara or something else. Young patient.

Gaurav Prakash M.D. (@drgprakash) 's Twitter Profile Photo

Rephrasing this phenomenal slide. Do not do an investigation just because you can order it. 💉📝 Medical field is reeling under overinvestigation epidemic.

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

The beauty of #MedTwitter We have the best nephropathogists and nephrologists giving input on management of a complex renal problem in a young patient.

Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Dr Dilip Jadhav Sanjeev Sethi Mayuri Trivedi Vijay Kher Sreejith Parameswaran Kenar Jhaveri Consensus based on all the replies is Proliferative glomerulonephritis with monoclonal immunoglobulin deposition (PGNMID) Sanjeev Sethi who described this entity provides input. fernando fervenza who’s ran the first Dara trial for PGNMID, and others recommend Dara.